BioInvent Signs Licensing Agreement With Daiichi Sankyo

BioInvent International AB has announced that it has entered into a license and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets.
Earth Times